BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32032379)

  • 1. Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application.
    Posocco B; Buzzo M; Poetto AS; Orleni M; Gagno S; Zanchetta M; Iacuzzi V; Guardascione M; Puglisi F; Basile D; Pelizzari G; Marangon E; Toffoli G
    PLoS One; 2020; 15(2):e0228822. PubMed ID: 32032379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
    Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry.
    Martínez-Chávez A; Rosing H; Hillebrand M; Tibben M; Schinkel AH; Beijnen JH
    Anal Bioanal Chem; 2019 Aug; 411(20):5331-5345. PubMed ID: 31209549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring in breast cancer therapy - LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serum.
    Habler K; Kalla AS; Rychlik M; Vogeser M; Teupser D
    J Pharm Biomed Anal; 2023 Feb; 225():115211. PubMed ID: 36603395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of total and unbound ribociclib in human plasma and brain tumor tissues using liquid chromatography coupled with tandem mass spectrometry.
    Bao X; Wu J; Sanai N; Li J
    J Pharm Biomed Anal; 2019 Mar; 166():197-204. PubMed ID: 30660034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of LC-MS/MS methods for the measurement of ribociclib, a CDK4/6 inhibitor, in mouse plasma and Ringer's solution and its application to a cerebral microdialysis study.
    Kala A; Patel YT; Davis A; Stewart CF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jul; 1057():110-117. PubMed ID: 28521250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring".
    Soledad Poetto A; Posocco B; Zanchetta M; Gagno S; Orleni M; Canil G; Alberti M; Puglisi F; Toffoli G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Sep; 1207():123403. PubMed ID: 35940043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of abemaciclib and letrozole in rat plasma: method development, validation and pharmacokinetic application.
    Dhakne P; Sahu AK; Sharma MK; Sengupta P
    Biomed Chromatogr; 2020 Jun; 34(6):e4825. PubMed ID: 32166756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Quantitative LC-MS/MS Method for CDK4/6 Inhibitors Palbociclib, Ribociclib, Abemaciclib, and Abemaciclib-M2 in Human Plasma.
    Burke SM; Kamal M; Goey AKL
    Ther Drug Monit; 2023 Jun; 45(3):327-336. PubMed ID: 36728357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method.
    Posocco B; Zanchetta M; Orleni M; Gagno S; Montico M; Peruzzi E; Roncato R; Gerratana L; Corsetti S; Puglisi F; Toffoli G
    Ther Drug Monit; 2024 Feb; ():. PubMed ID: 38366332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the aromatase inhibitor letrozole and its carbinol metabolite in mouse plasma by UHPLC-MS/MS.
    Taheri H; Jin Y; Ahmed E; Hu P; Li Y; Sparreboom A; Hu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 May; 1238():124106. PubMed ID: 38636136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple and rapid quantification of ribociclib in rat plasma by protein precipitation and LC-MS/MS: An application to pharmacokinetics of ribociclib nanoparticles in rats.
    Alshogran OY; Al-Shdefat R; Hailat M
    J Mass Spectrom; 2023 Dec; 58(12):e4984. PubMed ID: 37950646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.
    Turković L; Bočkor L; Ekpenyong O; Silovski T; Lovrić M; Crnković S; Nigović B; Sertić M
    Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of ribociclib in dried blood spots by LC-MS/MS: Method development and clinical validation.
    Braal CL; Lam MH; Rienks T; van Tilborg CJ; Heuts W; Heijns JB; Bos MEMM; Mathijssen RHJ; de Bruijn P; Koolen SLW
    J Pharm Biomed Anal; 2021 Jul; 201():114118. PubMed ID: 34000578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A validated simultaneous quantification method for vonoprazan (TAK-438F) and its 4 metabolites in human plasma by the liquid chromatography-tandem mass spectrometry.
    Yoneyama T; Teshima K; Jinno F; Kondo T; Asahi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():42-49. PubMed ID: 26896571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
    Marangon E; Buzzo M; Posocco B; Gagno S; Zanchetta M; Iacuzzi V; Poetto AS; Guardascione M; Giodini L; Toffoli G
    J Pharm Biomed Anal; 2020 Feb; 179():112949. PubMed ID: 31784210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A semi-automated LC-MS/MS method for the determination of LCI699, a steroid 11β-hydroxylase inhibitor, in human plasma.
    Li W; Luo S; Rebello S; Flarakos J; Tse FL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():182-93. PubMed ID: 24814004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of zolpidem in human plasma by liquid chromatography-tandem mass spectrometry for clinical application.
    Byeon JY; Lee HI; Lee YJ; Lee JE; Kim SH; Kim YH; Na HS; Jang CG; Lee SY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():129-34. PubMed ID: 25728370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser diode thermal desorption atmospheric pressure chemical ionization tandem mass spectrometry applied for the ultra-fast quantitative analysis of BKM120 in human plasma.
    Lanshoeft C; Heudi O; Leuthold LA; Schlotterbeck G; Elbast W; Picard F; Kretz O
    Anal Bioanal Chem; 2014 Sep; 406(22):5413-23. PubMed ID: 24958346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer.
    Bilgin B; Sendur MAN; Şener Dede D; Akıncı MB; Yalçın B
    Curr Med Res Opin; 2017 Sep; 33(9):1559-1569. PubMed ID: 28657360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.